These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31328339)

  • 1. Transvenous implantation of the Occlutech Atrial Flow Regulator: Preliminary results from swine models.
    McLennan D; Ivy D; Morgan GJ
    Congenit Heart Dis; 2019 Sep; 14(5):819-831. PubMed ID: 31328339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.
    Rajeshkumar R; Pavithran S; Sivakumar K; Vettukattil JJ
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1145-1153. PubMed ID: 28862384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage closure with a novel self-modelizing device: a pre-clinical feasibility study.
    Park JW; Sherif MA; Zintl K; Lam YY; Goedde M; Scharnweber T; Jung F; Franke RP; Brachmann J
    Int J Cardiol; 2014 Dec; 177(3):957-63. PubMed ID: 25449507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Septal Defect Closure with Occlutech
    Gonzalez-Barlatay F; Fournier A; Raboisson MJ; Dahdah N
    Pediatr Cardiol; 2017 Jan; 38(1):202-205. PubMed ID: 27872992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical assessment of a modified Occlutech left atrial appendage closure device in a canine model.
    Kim JS; Lee SG; Bong SK; Park SI; Hong SY; Shin S; Shim CY; Hong GR; Choi D; Jang Y; Park JW
    Int J Cardiol; 2016 Oct; 221():413-8. PubMed ID: 27404716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Holy Grail Deformity of Distal Disc Hubless Atrial Septal Occluders in Pediatric Hearts.
    Baspinar O; Sahin DA; Sulu A
    Int Heart J; 2015; 56(4):469-70. PubMed ID: 26104181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
    Boudjemline Y
    Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of a previous atrial septostomy in a patient with end-stage pulmonary hypertension by a manually fenestrated device.
    Baglini R; Scardulla C
    Cardiovasc Revasc Med; 2010; 11(4):264.e9-11. PubMed ID: 20934666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malposition of left atrial disc and feasibility of recapturing Figulla-II Occlutech septal occluder.
    Sadiq M; Qureshi AU; Amin Z
    Cardiol Young; 2020 Mar; 30(3):444-445. PubMed ID: 32066513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
    Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes.
    Lehner A; Schulze-Neick I; Fischer M; Fernandez-Rodriguez S; Ulrich S; Haas NA; Jakob A
    Curr Cardiol Rep; 2019 Mar; 21(5):31. PubMed ID: 30887235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter creation of a pulmonary artery to left atrial fenestration in a failing Fontan circulation using the Atrial Flow Regulator (AFR).
    Pascall E; Jones MI; Savis A; Rosenthal E; Qureshi SA
    Cardiol Young; 2021 Aug; 31(8):1376-1379. PubMed ID: 33766177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device.
    Kilic T; Ural E; Sahin T
    Tex Heart Inst J; 2015 Oct; 42(5):454-7. PubMed ID: 26504440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age.
    Ammar RI; Hegazy RA
    J Invasive Cardiol; 2013 Feb; 25(2):76-9. PubMed ID: 23388225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new Occlutech® PDA occluder: Initial human experience.
    Abdelbasit MA; Alwi M; Kandavello G; Che Mood M; Samion H; Hijazi ZM
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):94-9. PubMed ID: 25675888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept.
    Georgiev S; Tanase D; Genz T; Ewert P; Naumann S; Pozza RD; Eicken A
    Cardiol Young; 2018 Jul; 28(7):955-960. PubMed ID: 29779498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.